The response to TNF inhibitors (TNFi) is particularly influenced by BMI: in a meta-analysis including 22 cohorts with PsD, obesity was associated with poor response to TNFi in obese patients (OR for failing to respond to TNFi: 1.57 [1.30-1.89]) (68). Here, TNF is linked to obesity disorder.